PMS2 and digestive system cancer: To shed light on the simultaneous loss of expression in both functional MMR heterodimers (MLH1/PMS2, MSH2/MSH6), we retrospectively analyzed 352 cases of different digestive system cancer entities with differing dMMR frequencies (CRC, GC, small bowel carcinoma & ampullary cancer).